If the study is successful, the companies could submit the vaccine for regulatory approval as early as October, putting them on track to supply up to 100 million doses by the end of 2020 and 1.3 billion by the end of 2021.from Top World News- News18.com https://ift.tt/30V8HRE
No comments:
Post a Comment